Alphatec Holdings announced select preliminary financial results for the third quarter ended September 30 and updated full-year 2023 revenue guidance ahead of investor meetings scheduled during the 2023 North American Spine Society Annual Meeting. Preliminary Third Quarter 2023 Revenue Ranges Continued strong momentum of ATEC lateral adoption fueled preliminary, third quarter 2023 total revenue growth and surgical revenue growth of 31% to 32%. The Company now expects full-year 2023 revenue to approximate $472 million compared to the previous expectation of $462 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ATEC: